McKesson Corporation (MCK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, McKesson Corporation (MCK) has a cash flow conversion efficiency ratio of -4.102x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.42 Billion) by net assets ($-834.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See McKesson Corporation (MCK) net asset quality to measure how much of total assets are equity-financed.
McKesson Corporation - Cash Flow Conversion Efficiency Trend (1995–2026)
This chart illustrates how McKesson Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MCK cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
McKesson Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of McKesson Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Canadian Natural Resources Ltd
TO:CNQ
|
0.097x |
|
Mizuho Financial Group Inc
F:MZ8A
|
N/A |
|
Barclays PLC
MX:BCSN
|
N/A |
|
Marriott International Inc
NASDAQ:MAR
|
-0.210x |
|
Tata Consultancy Services Limited
NSE:TCS
|
0.134x |
|
Enel SpA
F:ENLA
|
0.103x |
|
PROSUS NV ADR/ 1/1
F:1YL
|
N/A |
|
Westpac Banking Corporation
AU:WBC
|
0.157x |
Annual Cash Flow Conversion Efficiency for McKesson Corporation (1995–2026)
The table below shows the annual cash flow conversion efficiency of McKesson Corporation from 1995 to 2026. For the full company profile with market capitalisation and key ratios, see MCK stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $-834.00 Million | $6.16 Billion | -7.380x | -105.45% |
| 2025-03-31 | $-1.69 Billion | $6.08 Billion | -3.592x | -33.14% |
| 2024-03-31 | $-1.60 Billion | $4.31 Billion | -2.698x | +22.08% |
| 2023-03-31 | $-1.49 Billion | $5.16 Billion | -3.462x | -39.93% |
| 2022-03-31 | $-1.79 Billion | $4.43 Billion | -2.474x | -178.77% |
| 2021-03-31 | $1.45 Billion | $4.54 Billion | 3.141x | +381.93% |
| 2020-03-31 | $6.71 Billion | $4.37 Billion | 0.652x | +56.32% |
| 2019-03-31 | $9.68 Billion | $4.04 Billion | 0.417x | +10.51% |
| 2018-03-31 | $11.52 Billion | $4.34 Billion | 0.377x | +0.21% |
| 2017-03-31 | $12.60 Billion | $4.74 Billion | 0.377x | +6.78% |
| 2016-03-31 | $10.41 Billion | $3.67 Billion | 0.353x | +7.31% |
| 2015-03-31 | $9.47 Billion | $3.11 Billion | 0.329x | +8.11% |
| 2014-03-31 | $10.32 Billion | $3.14 Billion | 0.304x | -13.46% |
| 2013-03-31 | $7.07 Billion | $2.48 Billion | 0.351x | -18.68% |
| 2012-03-31 | $6.83 Billion | $2.95 Billion | 0.432x | +33.36% |
| 2011-03-31 | $7.22 Billion | $2.34 Billion | 0.324x | +5.31% |
| 2010-03-31 | $7.53 Billion | $2.32 Billion | 0.307x | +40.95% |
| 2009-03-31 | $6.19 Billion | $1.35 Billion | 0.218x | +53.66% |
| 2008-03-31 | $6.12 Billion | $869.00 Million | 0.142x | -42.13% |
| 2007-03-31 | $6.27 Billion | $1.54 Billion | 0.245x | -47.19% |
| 2006-03-31 | $5.91 Billion | $2.74 Billion | 0.465x | +59.29% |
| 2005-03-31 | $5.28 Billion | $1.54 Billion | 0.292x | +167.37% |
| 2004-03-31 | $5.17 Billion | $563.40 Million | 0.109x | -25.90% |
| 2003-03-31 | $4.72 Billion | $695.50 Million | 0.147x | +84.89% |
| 2002-03-31 | $4.14 Billion | $329.30 Million | 0.080x | -16.83% |
| 2001-03-31 | $3.69 Billion | $353.10 Million | 0.096x | +186.55% |
| 2000-03-31 | $3.76 Billion | $-416.00 Million | -0.111x | -207.33% |
| 1999-03-31 | $3.08 Billion | $317.10 Million | 0.103x | +7404.23% |
| 1998-03-31 | $1.60 Billion | $2.20 Million | 0.001x | -99.16% |
| 1997-03-31 | $1.46 Billion | $238.10 Million | 0.164x | +7239.94% |
| 1996-03-31 | $1.12 Billion | $2.50 Million | 0.002x | -98.77% |
| 1995-03-31 | $1.07 Billion | $195.10 Million | 0.182x | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more